AS PER THE ATTACHED FILE
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Continental Chemicals reported total revenue of ₹167.20 lakh for FY2026, up 6.2% from ₹157.38 lakh in FY2025. However, profitability declined: PBT fell to ₹38.16 lakh from ₹43.19 lakh (down ~12%), and PAT dropped to ₹38.60 lakh from ₹43.73 lakh (down ~11.7%). EBITDA margin compressed from ~30.6% to ~27.1% year-on-year. Cash flow from operations turned negative at -₹11.88 lakh, compared to -₹10.25 lakh in the prior year. The statutory auditor SSVS & Company issued an Unmodified Opinion, though their peer review certificate had expired on April 30, 2026 (renewal application was submitted on March 7, 2026). No exceptional items were reported.
Revenue grew modestly but profitability and margins declined, and negative operating cash flow raises concerns about liquidity. The clean audit opinion provides some comfort, but worsening cash generation is a red flag for investors.